Cajeta, Jyff Yrll G.
HRN: 23-70-93 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/12/2023
09/19/2023
IV
500mg
Q8
Hypovolemic Shock Sec To AGE
Checking Final Appropriateness
09/13/2023
CIPROFLOXACIN 500MG (TAB)
09/13/2023
09/20/2023
PO
500mg
BID
Acute Gastroenteritis
Checking Final Appropriateness